Credit Suisse Ag Vera Therapeutics, Inc. Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
A detailed history of Credit Suisse Ag transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 28,254 shares of VERA stock, worth $985,782. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,254
Previous 19,937
41.72%
Holding current value
$985,782
Previous $306,000
298.04%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VERA
# of Institutions
173Shares Held
52.7MCall Options Held
117KPut Options Held
290K-
Avoro Capital Advisors LLC New York, NY5.27MShares$184 Million2.74% of portfolio
-
Black Rock Inc. New York, NY3.32MShares$116 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.17MShares$110 Million11.79% of portfolio
-
Abingworth LLP London, X02.96MShares$103 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$97.5 Million7.01% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $944M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...